Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 47, Pages 16826-16829
Publisher
Proceedings of the National Academy of Sciences
Online
2014-11-11
DOI
10.1073/pnas.1420281111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphoinositide 3-kinase p85beta regulates invadopodium formation
- (2014) A. E. Cariaga-Martinez et al. Biology Open
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
- (2012) Jean-Baptiste Rivière et al. NATURE GENETICS
- Somatic Mutations of PIK3R1 Promote Gliomagenesis
- (2012) Steven N. Quayle et al. PLoS One
- p85 phosphoinositide 3-kinase subunit regulates tumor progression
- (2012) I. Cortes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
- (2011) Ni Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Nuclear but Not Cytosolic Phosphoinositide 3-Kinase Beta Has an Essential Function in Cell Survival
- (2011) A. Kumar et al. MOLECULAR AND CELLULAR BIOLOGY
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
- (2011) Xuxiao Zhang et al. MOLECULAR CELL
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- The p85β regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling
- (2010) Jiman He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-126 functions as a tumour suppressor in human gastric cancer
- (2010) Runhua Feng et al. CANCER LETTERS
- Down-regulation of miR-126 expression in colorectal cancer and its clinical significance
- (2010) Xiang-Min Li et al. MEDICAL ONCOLOGY
- Cancer-derived mutations in the regulatory subunit p85 of phosphoinositide 3-kinase function through the catalytic subunit p110
- (2010) M. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p85 phosphoinositide 3-kinase regulates CD28 coreceptor function
- (2009) I. Alcazar et al. BLOOD
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
- (2009) Bo Liu et al. LUNG CANCER
- Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110 and are disrupted in oncogenic p85 mutants
- (2009) H. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cell growth suppressor, mir-126, targets IRS-1
- (2008) Jin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells
- (2008) Yoshimasa Saito et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Constitutively active Rheb induces oncogenic transformation
- (2008) H Jiang et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now